Rchr
J-GLOBAL ID:200901013129595240   Update date: Jul. 08, 2020

Takahashi Naoto

タカハシ ナオト | Takahashi Naoto
Affiliation and department:
Job title: Assistant Professor
Research field  (2): Hematology and oncology ,  Hematology and oncology
Research keywords  (1): hematological malignancy
Research theme for competitive and other funds  (2):
  • 2001 - Molecularcytogenetic analysis of malignant lymphoma and CML
  • 2000 - Clinicopathological study of hemophagocytic syndrome
Papers (72):
  • Masatoshi Sakurai, Shinichiro Okamoto, Itaru Matsumura, Satsuki Murakami, Makiko Takizawa, Masato Waki, Daiki Hirano, Reiko Watanabe-Nakaseko, Naoki Kobayashi, Masaki Iino, Hideki Mitsui, Yuichi Ishikawa, Naoto Takahashi, Tatsuya Kawaguchi, Ritsuro Suzuki, Kazuhito Yamamoto, Masahiro Kizaki, Kazunori Ohnishi, Tomoki Naoe, Koichi Akashi. Treatment outcomes of chronic-phase chronic myeloid leukemia with resistance and/or intolerance to a 1st-line tyrosine kinase inhibitor in Japan: the results of the New TARGET study 2nd-line. International journal of hematology. 2020
  • Takaya Yamashita, Kazuhiro Ikegame, Fumiko Ito, Takahiro Kobayashi, Miho Nara, Naohito Fujishima, Akira Anbai, Takayuki Inoue, Katsuji Kaida, Hidenori Tanaka, Naoto Takahashi. Effect of low platelet HLA-C expression on donor-specific antibody depletion following platelet transfusion from a corresponding HLA donor. Bone marrow transplantation. 2019. 54. 10. 1713-1716
  • Ikeda S, Kobayashi T, Saito M, Komatsuda A, Ubukawa K, Kameoka Y, Takahashi N. Multiparameter Flow Cytometry for the Identification of Neoplastic Plasma Cells in POEMS Syndrome with IgG-kappa Gammopathy: Successful Treatment Using Lenalidomide and Dexamethasone. Internal medicine (Tokyo, Japan). 2019
  • Hirabayashi S, Hasegawa D, Yamamoto K, Nishimura A, Hosoya Y, Shuo T, Kiyokawa N, Miura M, Takahashi N, Manabe A. Dasatinib and low-intensity chemotherapy for Philadelphia chromosome-positive acute lymphoblastic leukemia in a child with Down syndrome. Pediatric blood & cancer. 2019. 66. 5. e27612
  • Kobayashi T, Miura M, Abumiya M, Akamine Y, Ito F, Takahashi N. Influence of ABCB1 polymorphisms on the pharmacokinetics and toxicity of lenalidomide in patients with multiple myeloma. Medical oncology (Northwood, London, England). 2019. 36. 6. 55
more...
MISC (66):
  • 池田 翔, 阿部 史人, 北舘 明宏, 高橋 直人, 田川 博之. ヘキソキナーゼ-2は低酸素誘導性オートファジーを促進し、多発性骨髄腫のプロテアソーム阻害薬抵抗性を誘導する(Hexokinase-2(HK2) promotes hypoxia-inducible autophagy, leading to proteasome inhibitor resistance in multiple myeloma). 日本癌学会総会記事. 2019. 78回. J-1016
  • 池田 翔, 阿部 史人, 北舘 明宏, 小林 敬宏, 高橋 直人, 田川 博之. Hexokinase-2(HK2)は低酸素誘導性オートファジーを制御し骨髄腫細胞のプロテアソーム阻害薬耐性に寄与する(Hexokinase-2(HK2) regulates hypoxia-induced autophagy, leading to resistance of proteasome inhibitor of multiple myeloma). International Journal of Myeloma. 2019. 9. 1. 83-83
  • 池田 翔, 北舘 明宏, 阿部 史人, 高橋 直人, 田川 博之. 解糖系遺伝子HK2は骨髄低酸素微小環境に存在する骨髄腫細胞に対する治療標的となりうる(A glycolytic gene HK2 as a therapeutic target of myeloma cells in hypoxic microenvironment). 臨床血液. 2018. 59. 9. 1611-1611
  • 渡部 敦, 吉岡 智子, 伊藤 史子, 池田 翔, 郭 永梅, 奈良 美保, 藤島 眞澄, 藤島 直仁, 市川 善一, 中山 豊, 川端 良成, 北林 淳, 桑山 明久, 小笠原 仁, 井上 武, 茂木 睦仁, 仁村 隆, 三田 亜紀子, 道下 吉広, 波多野 善明, 伊藤 貢, 黒木 淳, 手島 和明, 大八木 秀明, 久米 正晃, 野口 晋佐, 鵜生川 久美, 亀岡 吉弘, 高橋 直人. 秋田県内の多施設調査による骨髄異形成症候群に対するアザシチジンの使用状況と安全性/有効性に関する検討(Azacitidine safety and efficacy in Myelodysplastic syndrome: A multicenter survey in Akita). 臨床血液. 2018. 59. 9. 1780-1780
  • 齋藤 雅也, 渡邊 春佳, 阿部 史人, 池田 翔, 奈良 瑞穂, 鵜生川 久美, 佐藤 隆太, 奥山 慎, 亀岡 吉弘, 小松田 敦, 高橋 直人. 腸炎を契機に発症した横紋筋融解に伴う急性腎障害. 日本腎臓学会誌. 2018. 60. 6. 902-902
more...
Education (3):
  • - 1997 Akita University Graduate School, Division of Medicine internal medicine
  • - 1990 Akita University School of Medicine School of Medicine
  • - 1990 Akita University Faculty of Medicine
Professional career (1):
  • Doctor of medical science (Akita University)
Work history (5):
  • 2015/02 - 現在 Akita University
  • 2005/09 - 2006/01 Akita University
  • 2002/03 - 2003/04 Akita University
  • 1997/04 - 2002/02 Akita University
  • 1993/04 - 1997/03 Akita University
Committee career (1):
  • The Japanese Society of Internal Medicine FJSIM
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page